The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

11 Apr 2018 07:00

RNS Number : 4917K
Spectra Systems Corporation
11 April 2018
 

Spectra Systems Corporation

("Spectra Systems" or the "Company")

Exercise of Options

Spectra Systems announces that on 9 April 2018 Martin Jaskel, Non-executive Director of the Company, exercised options over 33,869 shares of common stock of $0.01 in the Company ("Shares"). The Shares are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been or will be issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.

Accordingly the Company will apply for 33,869 Shares to be admitted to trading on AIM and it is anticipated that trading in such shares will commence on 16 April 2018 ("Admission").

Following Admission the Company's issued share capital will comprise:

656,710 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and

44,811,913 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).

Spectra Systems has no Shares in Treasury, therefore 45,468,623 may be used by Shareholders, from Admission, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Martin Jaskel

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Spectra Systems Corporation

b)

LEI

21380047EWJYQG53D640

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Regulation S restricted common stock of US$0.01

 

 

ISIN: [USU8457D1091] TIDM: [SPSC]

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$0.60 USD

33,869

d)

Aggregated information

- Aggregated volume

- Price

 

33,869

$0.60 USD

e)

Date of the transaction

9 April 2018

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFIDSVIILIT
Date   Source Headline
14th Jun 20217:00 amRNSAnnual General Meeting Update
17th May 20215:12 pmRNSShare Buy-Back
7th May 20214:49 pmRNSShare Buy-Back
6th May 20212:58 pmRNSShare Buy-Back
4th May 20215:51 pmRNSPosting of Annual Report and Accounts, AGM Notice
26th Apr 20211:45 pmRNSExercise of Options
22nd Apr 20217:00 amRNSNew Lottery Contracts
21st Apr 20217:00 amRNSEnhanced sensor capability contract
19th Apr 20211:46 pmRNSExercise of Options
8th Apr 20217:00 amRNSAllowance of Banknote Disinfection Patent
1st Apr 20213:29 pmRNSExercise of Options and Director/PDMR Shareholding
22nd Mar 20217:35 amRNSAudited Results for the 12 months ended 31 Dec 20
10th Feb 20217:00 amRNSExercise of Options
9th Feb 20212:11 pmRNSAppointment of Director
2nd Feb 20217:00 amRNSSecond phase of contract for sensor development
1st Feb 20213:33 pmRNSExercise of Options
20th Jan 20217:00 amRNSExercise of Options and Director/PDMR Shareholding
5th Jan 20214:02 pmRNSDirectorate
5th Jan 20217:00 amRNSShare Buy-Back
14th Dec 20207:01 amRNSTwo Lottery Renewals
14th Dec 20207:00 amRNSAcquisition of interest - Solaris BioSciences, Inc
21st Oct 20209:06 amRNSSecond Price Monitoring Extn
21st Oct 20209:01 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSContract with a Central Bank
14th Oct 20205:27 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSRemoval of Regulation S Restrictions
11th Sep 20204:34 pmRNSExercise of Options and Director/PDMR Shareholding
10th Sep 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
7th Sep 20207:00 amRNSInterim Results for the Six Months 30 June 20
25th Aug 20204:11 pmRNSHolding(s) in Company
15th Jul 20206:25 pmRNSDirector Dealings
9th Jul 20207:00 amRNSContract with a Major Central Bank
26th Jun 20207:00 amRNSShare Buy-Back
25th Jun 20207:00 amRNSShare Buy-Back and Removal of Reg S Restrictions
16th Jun 20203:23 pmRNSShare Buy-Back
10th Jun 20207:00 amRNSAsian Central Bank Contract Update
26th May 20207:00 amRNSDirector Dealings
15th May 20205:24 pmRNSExercise of Options and Removal of Regulation S
30th Apr 20208:51 amRNSPosting of Annual Report and Accounts
3rd Apr 20204:56 pmRNSShare Buy-Back and Removal of Reg S Restrictions
23rd Mar 202012:37 pmRNSAudited Results
16th Mar 20201:59 pmRNSHolding(s) in Company
9th Mar 20204:41 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSShare Buy-Back
11th Nov 20193:30 pmRNSHolding(s) in Company
30th Oct 20191:39 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSHolding(s) in Company
25th Sep 20192:59 pmRNSHolding(s) in Company
24th Sep 20197:00 amRNSInterim Results
17th Sep 20197:00 amRNSFunding Approval - G7 Central Bank

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.